Education
About Us
Working with TipRanks
Follow Us
Tenet Healthcare Corp. (CH:THC1)
:THC1
Earnings Data
Report Date
Apr 29, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
2.56Last Year’s EPS
2.63Same Quarter Last Year
Strong Buy
Based on 16 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 29, 2025
|% Change Since: ―
|Next Earnings Date:Jul 17, 2025
Earnings Call Sentiment|Neutral
Tenet Healthcare demonstrated strong financial performance and strategic growth in 2024, particularly in its USPI segment and through share repurchases. However, challenges such as the impact of hospital divestitures and non-recurring Medicaid payments present potential headwinds. Overall, the company's results and outlook suggest a balanced approach to managing growth and operational efficiency.Company Guidance
During Tenet Healthcare's fourth-quarter 2024 earnings call, the company provided guidance for 2025, projecting full-year adjusted EBITDA between $3.975 billion and $4.175 billion, indicating a 7% growth at the midpoint on a normalized basis. Specifically, they anticipate USPI's adjusted EBITDA growth of approximately 8.5%, driven by 3% to 6% same-facility revenue growth, and the addition of 10 to 12 de novo centers. The Hospital segment is expected to see a 5.7% growth in adjusted EBITDA, with 2% to 3% growth in adjusted admissions. The company also plans to invest around $250 million annually in ambulatory M&A. Tenet aims for net operating revenues between $20.6 billion and $21.0 billion for the year, reflecting robust operational efficiencies and disciplined cost management. Additionally, they expect to have substantial free cash flow, projected between $1.8 billion and $2.05 billion, after capital expenditures of $700 million to $800 million.Strong Financial Performance
Tenet Healthcare reported operating revenues of $20.7 billion and consolidated adjusted EBITDA of $4 billion for 2024, representing a 13% growth over 2023.
Improved EBITDA Margin
Full-year adjusted EBITDA margin improved by over 200 basis points to 19.3% compared to the previous year.
USPI Segment Growth
USPI generated $1.81 billion in adjusted EBITDA in 2024, marking a 17% growth over 2023, with adjusted EBITDA margins of 42.1%.
Hospital Segment Performance
Despite the sale of 14 hospitals, the Hospital segment achieved $2.185 billion of adjusted EBITDA in 2024, a 9% increase over the prior year.
Significant Share Repurchase
Tenet returned capital to shareholders by repurchasing approximately 14% of its outstanding shares for $1.12 billion since the fourth quarter of 2022.
Deleveraged Balance Sheet
Year-end leverage ratio improved to 2.5x EBITDA, supported by hospital divestitures and strong operational performance.
---
CH:THC1 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CH:THC1 Earnings-Related Price Changes
No data currently available
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Tenet Healthcare Corp. (CH:THC1) report earnings?
Tenet Healthcare Corp. (CH:THC1) is schdueled to report earning on Apr 29, 2025, TBA Not Confirmed.
What is Tenet Healthcare Corp. (CH:THC1) earnings time?
Tenet Healthcare Corp. (CH:THC1) earnings time is at Apr 29, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Tenet Healthcare Corp. stock?
The P/E ratio of Tenet Healthcare is N/A.
What is CH:THC1 EPS forecast?
CH:THC1 EPS forecast for the fiscal quarter 2025 (Q1) is 2.56.
---